Immuron LimitedASX: IMC

Form F-3

· Issued by Immuron Limited

Filed with ASX · · 47 pages · English

Melbourne, Australia, January 15, 2019: Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian microbiome biopharmaceutical company wishes to advise that it has filed its Registration Statement on Form F-3 with the US Securities and Exchange Commission. A copy of the Form F-3 has been appended to this announcement. ---End--- COMPANY CONTACT: USA INVESTOR RELATIONS: AUS INVESTOR RELATIONS: Gary S.

Immuron Limited on 6ix

Earlier from Immuron

Later from Immuron

All Immuron news releases